Bank of New York Mellon Corp Sells 25,922 Shares of Astera Labs, Inc. $ALAB

Bank of New York Mellon Corp lessened its position in Astera Labs, Inc. (NASDAQ:ALAB) by 5.2% during the 1st quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 475,520 shares of the company’s stock after selling 25,922 shares during the period. Bank of New York Mellon Corp’s holdings in Astera Labs were worth $52,117,000 as of its most recent filing with the SEC.

Several other large investors have also made changes to their positions in ALAB. Reflection Asset Management acquired a new stake in shares of Astera Labs during the 4th quarter worth about $25,000. Smartleaf Asset Management LLC lifted its holdings in Astera Labs by 422.2% during the 4th quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock valued at $32,000 after purchasing an additional 152 shares during the last quarter. Towarzystwo Funduszy Inwestycyjnych PZU SA acquired a new position in Astera Labs in the fourth quarter valued at about $33,000. Whipplewood Advisors LLC boosted its position in Astera Labs by 15,950.0% in the first quarter. Whipplewood Advisors LLC now owns 321 shares of the company’s stock valued at $35,000 after buying an additional 319 shares in the last quarter. Finally, Assetmark Inc. grew its stake in Astera Labs by 78.9% during the fourth quarter. Assetmark Inc. now owns 229 shares of the company’s stock worth $38,000 after buying an additional 101 shares during the last quarter. Institutional investors own 60.47% of the company’s stock.

Astera Labs Trading Down 1.2%

ALAB opened at $326.97 on Friday. Astera Labs, Inc. has a 1-year low of $97.89 and a 1-year high of $499.48. The stock has a market capitalization of $56.05 billion, a PE ratio of 220.93, a PEG ratio of 3.83 and a beta of 3.66. The firm has a 50-day moving average price of $357.77 and a two-hundred day moving average price of $225.19.

Astera Labs (NASDAQ:ALAB) last announced its earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.54 by $0.07. The company had revenue of $308.36 million for the quarter, compared to analyst estimates of $292.19 million. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. Astera Labs’s quarterly revenue was up 93.5% on a year-over-year basis. During the same period in the prior year, the business earned $0.33 earnings per share. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, research analysts predict that Astera Labs, Inc. will post 1.86 EPS for the current year.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on ALAB. Needham & Company LLC raised their price objective on shares of Astera Labs from $220.00 to $260.00 and gave the stock a “buy” rating in a report on Wednesday, May 6th. Rothschild & Co Redburn started coverage on Astera Labs in a research report on Friday, May 1st. They set a “neutral” rating and a $153.00 price target on the stock. Weiss Ratings upgraded Astera Labs from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, May 21st. TD Cowen lifted their price objective on Astera Labs from $225.00 to $425.00 and gave the company a “hold” rating in a research report on Monday, July 13th. Finally, Jefferies Financial Group reiterated a “buy” rating and issued a $270.00 price objective on shares of Astera Labs in a research report on Wednesday, May 6th. Twelve equities research analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $282.00.

Insiders Place Their Bets

In other Astera Labs news, Director Manuel Alba sold 136,974 shares of the company’s stock in a transaction on Wednesday, July 1st. The stock was sold at an average price of $442.01, for a total transaction of $60,543,877.74. Following the transaction, the director owned 1,287,524 shares of the company’s stock, valued at approximately $569,098,483.24. This represents a 9.62% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO Sanjay Gajendra sold 400,000 shares of the stock in a transaction on Thursday, May 21st. The shares were sold at an average price of $290.30, for a total value of $116,120,000.00. Following the completion of the transaction, the chief operating officer owned 5,064,213 shares in the company, valued at $1,470,141,033.90. The trade was a 7.32% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders have sold 1,676,845 shares of company stock valued at $444,928,806. 10.40% of the stock is currently owned by corporate insiders.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.